A Phase IIa Intrapatient Dose Escalation Study of Desipramine in Small Cell Lung Cancer and Other High-Grade Neuroendocrine Tumors
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Desipramine (Primary)
- Indications Neuroendocrine tumours; Small cell lung cancer
- Focus Biomarker; Therapeutic Use
- 17 Apr 2017 Biomarkers information updated
- 05 Dec 2012 New trial record